Capital Analysts LLC’s Bio-Techne TECH Stock Holding History

Capital Analysts LLC’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,600	Closed	-$153K	–	1079
2021 Q1	$153K	Buy	+1,600	New	+$146K	0.01%	376

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Analysts LLC's TECH Position: Q2 2021 in Review

Capital Analysts LLC sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 1,600 shares — an estimated $153K sold.

Capital Analysts LLC first reported a position in TECH in Q1 2021 and held it in 1 quarter. The position peaked at $153K in Q1 2021. 511 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

Capital Analysts LLC reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
Capital Analysts LLC sold 1,600 Bio-Techne shares in Q2 2021, an estimated $153K.
Capital Analysts LLC first reported a position in Bio-Techne in Q1 2021 and held it in 1 quarter.
Capital Analysts LLC's Bio-Techne position peaked at $153K in Q1 2021.
511 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on Capital Analysts LLC's 13F filing for Q2 2021, filed 5 Aug 2021.